Page last updated: 2024-11-13

lhrh, pglu(1)-phe(2)-trp(3,6)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

LHRH, pGlu(1)-Phe(2)-Trp(3,6)-: gonadorelin antagonist; RN given refers to (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25078138
MeSH IDM0106343

Synonyms (12)

Synonym
68059-94-9
gnrh, pglu(1)-phe(2)-trp(3,6)-
lhrh, pglu(1)-phe(2)-trp(3,6)-
lhrh, pyroglutamyl(1)-phenylalanyl(2)-tryptophyl(3,6)-
lhrh,-pyroglutamyl(1)-phenylalanyl(2)-tryptophyl(3,6)-
lhrh, d-pglu(1)-d-phe(2)-d-trp(3,6)-
1-pyr-2-phe-3,6-trp-lhrh
[d-pglu1, d-phe2, d-trp3,6]-lh-rh, >=97% (hplc)
glycinamide,5-oxo-d-prolyl-d-phenylalanyl-d-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl-l-prolyl-(9ci)
CS-0617604
HY-P3671
[d-glp1,d-phe2,d-trp3,6]-lh-rh

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves revealed that adult animals were more than 10-fold less sensitive to NMDA than their younger counterparts."( Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat.
Bell, RD; Cicero, TJ; Meyer, ER, 1988
)
0.27
" Most importantly, however, we showed that the GPT-LHRH produced equivalent, parallel shifts to the right in the dose-response curves for LHRH and naloxone, indicative of competitive inhibition."( Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
Cicero, TJ; Meyer, ER; Miller, BT; Schmoeker, PF, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (73.68)18.7374
1990's4 (21.05)18.2507
2000's1 (5.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.92 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.01 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]